Senior insider sale
EVP, CFO & CBO at DIANTHUS THERAPEUTICS, INC. /DE/ — senior position signals high conviction
$9.09M
114.37K shares
What this filing means
SAVITZ RYAN plans to sell 114.37K shares of DIANTHUS THERAPEUTICS, INC. /DE/ valued at approximately $9.09M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/31/2026ACC: 0001950047-26-003101
Officer· EVP, CFO & CBO
Since Feb 2026
114.37K
Shares to sell
$9.09M
Approx. market value
114.37K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
3/31/2026
114.37KTotal acquired114.37K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/31/2026 | Exercise of Stock Options Cash | 114.37K | — |
| Total | 114.37K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
114.37K
Market value
$9.09M
3/31/2026
Total
Units
114.37K
Value
$9.09M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/31/2026 | 114.37K | $9.09M | NASDAQ | Planned |
| Total | 114.37K | $9.09M | ||